Elevance Health (ELV) Initiated with a Buy at Cantor Fitzgerald
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Elevance Health (ELV) Receives a Buy from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a ...
Ballentine Partners LLC Trims Stake in Elevance Health, Inc. (NYSE:ELV)
Ballentine Partners LLC lessened its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 26.5% during the ...
Elevance Earnings: Stock Rises After Results, Guidance Match Expectations
Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t ...
Health Care Up as Elevance Rises on Earnings -- Health Care Roundup
Health-care companies rose sharply amid strong earnings.
Benefits Pro22h
Elevance expects commercial health cost trends to stay high
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
marketinference23h
Elevance Health Reports Strong Financial Performance
Elevance Health's quarterly dividend has been increased by 5% to $1.71 per share. The company's president and CEO, Gail K. Boudreaux, expressed the commitment to simplifying the healthcare experience ...
Benefits Pro23h
Elevance is glad it raised commercial health insurance prices for 2025
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...